Mirakhur B - Search Results

1

Liposomal irinotecan and 5-fluorouracil/leucovorin in older patients with metastatic pancreatic cancer - A subgroup analysis of the pivotal NAPOLI-1 trial.

Macarulla T, Blanc JF, Wang-Gillam A, Chen LT, Siveke JT, Mirakhur B, Chen J, de Jong FA. Macarulla T, et al. Among authors: mirakhur b. J Geriatr Oncol. 2019 May;10(3):427-435. doi: 10.1016/j.jgo.2019.02.011. Epub 2019 Mar 4. J Geriatr Oncol. 2019. PMID: 30842038 Free article. Clinical Trial.

2

NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors.

Wang-Gillam A, Hubner RA, Siveke JT, Von Hoff DD, Belanger B, de Jong FA, Mirakhur B, Chen LT. Wang-Gillam A, et al. Among authors: mirakhur b. Eur J Cancer. 2019 Feb;108:78-87. doi: 10.1016/j.ejca.2018.12.007. Epub 2019 Jan 14. Eur J Cancer. 2019. PMID: 30654298 Free article. Clinical Trial.

3

Nomogram for Predicting Survival in Patients Treated with Liposomal Irinotecan Plus Fluorouracil and Leucovorin in Metastatic Pancreatic Cancer.

Chen LT, Macarulla T, Blanc JF, Mirakhur B, Jong FA, Belanger B, Bekaii-Saab T, Siveke JT. Chen LT, et al. Among authors: mirakhur b. Cancers (Basel). 2019 Jul 28;11(8):1068. doi: 10.3390/cancers11081068. Cancers (Basel). 2019. PMID: 31357748 Free PMC article.

4

Early dose reduction/delay and the efficacy of liposomal irinotecan with fluorouracil and leucovorin in metastatic pancreatic ductal adenocarcinoma (mPDAC): A post hoc analysis of NAPOLI-1.

Chen LT, Macarulla T, Blanc JF, Mirakhur B, de Jong FA, Belanger B, Bekaii-Saab T, Siveke JT. Chen LT, et al. Among authors: mirakhur b. Pancreatology. 2021 Jan;21(1):192-199. doi: 10.1016/j.pan.2020.10.029. Epub 2020 Oct 10. Pancreatology. 2021. PMID: 33214082 Free article. Clinical Trial.

5

Treatment Outcomes in Patients with Metastatic Neuroendocrine Tumors: a Retrospective Analysis of a Community Oncology Database.

Fisher MD, Pulgar S, Kulke MH, Mirakhur B, Miller PJ, Walker MS, Schwartzberg LS. Fisher MD, et al. Among authors: mirakhur b. J Gastrointest Cancer. 2019 Dec;50(4):816-823. doi: 10.1007/s12029-018-0160-x. J Gastrointest Cancer. 2019. PMID: 30121904 Free PMC article.

6

Novel Tumor Growth Rate Analysis in the Randomized CLARINET Study Establishes the Efficacy of Lanreotide Depot/Autogel 120 mg with Prolonged Administration in Indolent Neuroendocrine Tumors.

Dromain C, Loaiza-Bonilla A, Mirakhur B, Beveridge TJR, Fojo AT. Dromain C, et al. Among authors: mirakhur b. Oncologist. 2021 Apr;26(4):e632-e638. doi: 10.1002/onco.13669. Epub 2021 Feb 1. Oncologist. 2021. PMID: 33393112 Free PMC article.

7

Medical record review of transition to lanreotide following octreotide for neuroendocrine tumors.

Saif MW, Parikh R, Ray D, Kaye JA, Kurosky SK, Thomas K, Ramirez RA, Halfdanarson TR, Beveridge TJR, Mirakhur B, Nagar SP, Soares HP. Saif MW, et al. Among authors: mirakhur b. J Gastrointest Oncol. 2019 Aug;10(4):674-687. doi: 10.21037/jgo.2019.03.11. J Gastrointest Oncol. 2019. PMID: 31392048 Free PMC article.

8

Effect of Lanreotide Depot/Autogel on Urinary 5-Hydroxyindoleacetic Acid and Plasma Chromogranin A Biomarkers in Nonfunctional Metastatic Enteropancreatic Neuroendocrine Tumors.

Pavel ME, Phan AT, Wolin EM, Mirakhur B, Liyanage N, Pitman Lowenthal S, Fisher GA Jr, Vinik AI; CLARINET Study Investigators. Pavel ME, et al. Among authors: mirakhur b. Oncologist. 2019 Apr;24(4):463-474. doi: 10.1634/theoncologist.2018-0217. Epub 2018 Oct 24. Oncologist. 2019. PMID: 30355775 Free PMC article. Clinical Trial.

9

Treatment Patterns and Clinical Outcomes in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors Treated in the Community Practice Setting in the United States.

Jiao X, Pulgar S, Boyd M, Braiteh F, Mirakhur B, Pitman Lowenthal S, Fox P, Frytak J, Cox D, Paulson AS. Jiao X, et al. Among authors: mirakhur b. Pancreas. 2018 Feb;47(2):173-182. doi: 10.1097/MPA.0000000000000955. Pancreas. 2018. PMID: 29206668

10

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals.

Ortendahl JD, Pulgar SJ, Mirakhur B, Cox D, Bentley TG, Phan AT. Ortendahl JD, et al. Among authors: mirakhur b. Clinicoecon Outcomes Res. 2017 Aug 16;9:495-503. doi: 10.2147/CEOR.S140866. eCollection 2017. Clinicoecon Outcomes Res. 2017. PMID: 28860831 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

30 results

Search Page